Medicare nationalized the payment rate for skin substitute grafts on January 1, 2026, but left coverage exactly where it was: split across separate regional contractors, each running its own rulebook. CMS finalized a flat rate of $127.14 per square centimeter for most skin substitutes under the CY 2026 Medicare Physician Fee Schedule Final Rule (CMS-1832-F), replacing the prior product-specific pricing. Days before that rate took effect, CMS withdrew the unified national coverage policy meant to accompany it, so each Medicare Administrative Contractor (MAC) still applies its own Local Coverage Determination (LCD) for skin substitute application, debridement, and the conservative care that has to precede both. A practice billing the same graft the same way in two states can pass one MAC's review and fail another's.

Why the LCD Withdrawal Matters for Skin Substitute Claims

CMS had drafted a single, unified Local Coverage Determination for skin substitute grafts, set to take effect alongside the new payment rate on January 1, 2026. On December 24, 2025, CMS directed its Medicare Administrative Contractors to withdraw that LCD first, citing the need for additional peer-reviewed evidence. The payment rate under CMS-1832-F stayed in place. Each MAC's existing coverage policy remained standing instead, so the criteria a claim has to satisfy, wound measurements, debridement documentation, and how long conservative care has to fail before a skin substitute is medically necessary, still depend on which MAC processes the claim. CMS has not said when, or whether, a revised unified standard will follow.

How Coverage Criteria Vary by MAC Jurisdiction

Coverage of skin substitute application, debridement, and the wound care that precedes both runs through separate MAC jurisdictions, including Novitas, National Government Services (NGS), Palmetto GBA, Noridian, and WPS. Each publishes its own LCD, and the details deciding whether a claim survives review are not uniform. A conservative-care trial that satisfies one MAC's standard, typically a defined period of standard wound care that failed before a skin substitute became medically necessary, does not automatically satisfy another MAC's version of the same requirement. Application frequency limits within an episode of care differ by jurisdiction too, and so does the detail a MAC expects for debridement depth and wound measurements.

A documentation template built for one Medicare Administrative Contractor's Local Coverage Determination does not protect a claim reviewed under a different MAC's LCD.

Building Documentation to the Applicable LCD

The practical fix is identifying the correct LCD before treatment, not after a Targeted Probe and Educate (TPE) audit letter arrives. Every wound care chart should show the wound's baseline measurements (length, width, depth), a documented method of debridement, and a conservative-care record showing how long standard treatment failed before a skin substitute was applied, matched to the duration and thresholds the treating MAC's LCD requires. Application counts within an episode of care need to track that same LCD's frequency limit, not a different jurisdiction's. Every entry also needs a legible, dated signature log identifying which clinician performed the debridement or application; auditors treat a missing signature the same as a missing service.

Audit Exposure Under the New Payment Rate

The new flat rate has not reduced MAC scrutiny of skin substitute claims, in office-based practices or hospital outpatient departments. Medicare Administrative Contractors have opened Targeted Probe and Educate audits of wound care and skin substitute billing across jurisdictions, and Unified Program Integrity Contractors (UPICs) and the Office of Inspector General (OIG) have flagged skin substitute claims as a priority area heading into 2026. A claim that would have been paid under the old per-product pricing can still be denied, and referred, if the chart does not satisfy the applicable MAC's LCD.

Why Early Legal Counsel Is Critical

It is critical that wound care providers promptly retain experienced healthcare defense counsel upon receiving a Targeted Probe and Educate notice, an audit request, or any other government inquiry involving skin substitute or debridement billing. Early legal intervention can protect the provider's rights, ensure documentation is mapped to the correct MAC's LCD before it reaches reviewers, avoid inadvertent admissions, preserve relevant defenses, and allow counsel to communicate with the contractor on the provider's behalf. Delaying legal representation can significantly affect the outcome of a matter.

How Health Law Alliance Can Help

Health Law Alliance defends wound care providers and skin substitute billers against Medicare audits nationwide, from the first documentation request through appeal. Our bench includes attorneys who have handled MAC audits across Novitas, NGS, Palmetto GBA, Noridian, and WPS jurisdictions, matching a provider's chart against the specific LCD the contractor is applying. If your practice bills skin substitutes or debridement and has received a Targeted Probe and Educate notice or another audit request, contact us today for a free consultation.